TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Precision Diagnostics Market – By Type
1.3.2 North America Precision Diagnostics Market – By Application
1.3.3 North America Precision Diagnostics Market – By End User
1.3.4 North America Precision Diagnostics Market – By Country
2. North America Precision Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Precision Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Expert Opinion
5. North America Precision Diagnostics Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Demand for Personalized Medicine
5.1.2 Rising Application in Oncology and Other Disorders
5.2 Market Restraints
5.2.1 High Investments Involved in the R&D of Precision Medicine and Diagnostic Kits
5.3 Market Opportunities
5.3.1 Growing Advancement In Digital Solutions
5.4 Future Trends
5.4.1 Usage of Artificial Intelligence and Machine Learning in Precision Diagnostics
5.5 Impact Analysis
6. Precision Diagnostics Market– North America Analysis
6.1 North America Precision Diagnostics Market Revenue Forecast and Analysis
7. North America Precision Diagnostics Market– by Type
7.1 Overview
7.2 Genetic Tests
7.2.1 Overview
7.2.2 Genetic Tests: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
7.3 Esoteric Tests
7.3.1 Overview
7.3.2 Esoteric Tests: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8. North America Precision Diagnostics Market– by Application
8.1 Overview
8.2 Oncology
8.2.1 Overview
8.2.2 Oncology: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3 Cardiology
8.3.1 Overview
8.3.2 Cardiology: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Respiratory Diseases
8.4.1 Overview
8.4.2 Respiratory Diseases: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Immunology
8.5.1 Overview
8.5.2 Immunology: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. North America Precision Diagnostics Market– by End User
9.1 Overview
9.2 Clinical Laboratories
9.2.1 Overview
9.2.2 Clinical Laboratories: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Homecare
9.4.1 Overview
9.4.2 Homecare: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: North America Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. North America Precision Diagnostics Market– by Country
10.1 North America: Precision Diagnostics Market– Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 North America Precision Diagnostics Market, by Country, 2022 & 2028 (%)
10.1.2.1 US: Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 US: Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2 US Precision Diagnostics Market Revenue and Forecast to 2028, By Type (US$ Million)
10.1.2.1.3 US Precision Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)
10.1.2.1.4 US Precision Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.2.2 Canada: Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Canada: Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2 Canada Precision Diagnostics Market Revenue and Forecast to 2028, By Type (US$ Million)
10.1.2.2.3 Canada Precision Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)
10.1.2.2.4 Canada Precision Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.2.3 Mexico: Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Mexico: Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2 Mexico Precision Diagnostics Market Revenue and Forecast to 2028, By Type (US$ Million)
10.1.2.3.3 Mexico Precision Diagnostics Market Revenue and Forecast to 2028, By Application (US$ Million)
10.1.2.3.4 Mexico Precision Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
11. North America Precision Diagnostics Market –Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.2.2 Organic Growth Strategies in the Precision Diagnostics Market, 2018-2022
11.3 Inorganic Developments
11.3.1 Overview
11.3.2 Inorganic Growth Strategies in the Precision Diagnostics Market, 2018-2022
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 QIAGEN
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Swiss Precision Diagnostics GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips N.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Lantheus Medical Imaging, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Siemens Healthineers AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Abbott
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Novartis AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Sanofi
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Bayer AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms